| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.848 | 0.005 | 0.848 | Caspase 9 stimulant | 0.835 0.007 CID_154699903 | ||
| 0.771 | 0.005 | 0.771 | Aldehyde oxidase inhibitor | |||
| 0.748 | 0.005 | 0.748 | Amyloid beta aggregation inhibitor | 0.478 0.016 CID_154699903 | ||
| 0.727 | 0.004 | 0.727 | Superoxide dismutase inhibitor | 0.186 0.134 CID_154699903 | ||
| 0.67 | 0.005 | 0.74 | Free radical scavenger | 0.74 0.005 CID_154699903 | CID_154699903 | |
| 0.683 | 0.034 | 0.744 | Apoptosis agonist | 0.744 0.024 CID_154699903 | CID_154699903 | |
| 0.647 | 0.008 | 0.779 | Antioxidant | 0.779 0.005 CID_154699903 | CID_154699903 | |
| 0.629 | 0.005 | 0.629 | Tubulin antagonist | 0.193 0.039 CID_154699903 | ||
| 0.61 | 0.013 | 0.61 | 12-Lipoxygenase inhibitor | |||
| 0.585 | 0.005 | 0.585 | Peroxidase inhibitor | |||
| 0.593 | 0.032 | 0.849 | Transcription factor NF kappa B inhibitor | 0.849 0.01 CID_154699903 | CID_154699903 | |
| 0.557 | 0.013 | 0.557 | Lipoxygenase inhibitor | |||
| 0.551 | 0.014 | 0.551 | Caspase 3 stimulant | 0.477 0.024 CID_154699903 | ||
| 0.531 | 0.005 | 0.788 | Amylase inhibitor | 0.788 0.002 CID_154699903 | CID_154699903 | |
| 0.523 | 0.003 | 0.523 | Cystathionine beta-synthase inhibitor | 0.439 0.004 CID_154699903 | ||
| 0.529 | 0.014 | 0.607 | Antiamyloidogenic | 0.607 0.008 CID_154699903 | CID_154699903 | |
| 0.516 | 0.007 | 0.783 | Monophenol monooxygenase inhibitor | 0.783 0.003 CID_154699903 | CID_154699903 | |
| 0.503 | 0.007 | 0.694 | Melanin inhibitor | 0.694 0.003 CID_154699903 | CID_154699903 | |
| 0.504 | 0.012 | 0.504 | Antimitotic | 0.288 0.047 CID_154699903 | ||
| 0.516 | 0.025 | 0.516 | 5 Hydroxytryptamine release stimulant | 0.311 0.066 CID_154699903 | ||
| 0.507 | 0.024 | 0.507 | GABA C receptor rho-3 antagonist | |||
| 0.498 | 0.03 | 0.599 | Histamine release inhibitor | 0.599 0.01 CID_154699903 | CID_154699903 | |
| 0.497 | 0.033 | 0.564 | 5 Hydroxytryptamine release inhibitor | 0.564 0.017 CID_154699903 | CID_154699903 | |
| 0.47 | 0.008 | 0.47 | Calcium channel activator | 0.275 0.119 CID_154699903 | ||
| 0.487 | 0.025 | 0.487 | Aryl hydrocarbon receptor agonist | 0.147 0.138 CID_154699903 | ||
| 0.469 | 0.012 | 0.469 | Pyruvate kinase inhibitor | 0.15 0.115 CID_154699903 | ||
| 0.498 | 0.041 | 0.498 | 15-Lipoxygenase inhibitor | |||
| 0.478 | 0.036 | 0.691 | Cholesterol antagonist | 0.691 0.009 CID_154699903 | CID_154699903 | |
| 0.443 | 0.004 | 0.443 | Beta tubulin antagonist | |||
| 0.512 | 0.077 | 0.748 | Alpha-glucosidase inhibitor | 0.748 0.026 CID_154699903 | CID_154699903 | |
| 0.458 | 0.038 | 0.458 | Vasodilator, peripheral | 0.433 0.046 CID_154699903 | ||
| 0.44 | 0.025 | 0.655 | Vasodilator, coronary | 0.655 0.005 CID_154699903 | CID_154699903 | |
| 0.437 | 0.03 | 0.437 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.402 | 0.005 | 0.402 | Breast cancer-resistant protein inhibitor | |||
| 0.399 | 0.004 | 0.399 | Carbonic anhydrase III inhibitor | 0.235 0.011 CID_154699903 | ||
| 0.402 | 0.008 | 0.402 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.4 | 0.008 | 0.539 | Protein kinase stimulant | 0.539 0.003 CID_154699903 | CID_154699903 | |
| 0.395 | 0.004 | 0.395 | Carbonic anhydrase XV inhibitor | 0.089 0.085 CID_154699903 | ||
| 0.396 | 0.008 | 0.471 | NOS3 expression enhancer | 0.471 0.005 CID_154699903 | CID_154699903 | |
| 0.412 | 0.027 | 0.443 | Hypoxia-inducible factor 1 alpha inhibitor | 0.443 0.021 CID_154699903 | CID_154699903 | |
| 0.387 | 0.007 | 0.387 | Amyloid beta precursor protein antagonist | 0.168 0.083 CID_154699903 | ||
| 0.383 | 0.004 | 0.383 | Alpha tubulin antagonist | |||
| 0.381 | 0.003 | 0.381 | Keratolytic | 0.091 0.037 CID_154699903 | ||
| 0.396 | 0.028 | 0.731 | Hypoglycemic | 0.731 0.005 CID_154699903 | CID_154699903 | |
| 0.38 | 0.013 | 0.38 | MAO inhibitor | |||
| 0.371 | 0.006 | 0.371 | 5-Lipoxygenase inhibitor | |||
| 0.375 | 0.011 | 0.44 | Lipid peroxidase inhibitor | 0.44 0.008 CID_154699903 | CID_154699903 | |
| 0.36 | 0.005 | 0.36 | Carbonic anhydrase VI inhibitor | 0.169 0.017 CID_154699903 | ||
| 0.373 | 0.02 | 0.373 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.378 | 0.025 | 0.378 | Sigma receptor agonist | |||
| 0.393 | 0.04 | 0.58 | Apoptosis antagonist | 0.58 0.012 CID_154699903 | CID_154699903 | |
| 0.378 | 0.028 | 0.555 | Nitric oxide antagonist | 0.555 0.012 CID_154699903 | CID_154699903 | |
| 0.353 | 0.008 | 0.353 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.365 | 0.028 | 0.365 | Transcription factor STAT3 inhibitor | 0.21 0.121 CID_154699903 | ||
| 0.345 | 0.013 | 0.345 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.274 0.033 CID_154699903 | ||
| 0.335 | 0.005 | 0.335 | Estrogen antagonist | 0.112 0.071 CID_154699903 | ||
| 0.334 | 0.004 | 0.334 | Macrophage migration inhibitory factor inhibitor | |||
| 0.351 | 0.025 | 0.505 | Cyclic AMP phosphodiesterase inhibitor | 0.505 0.006 CID_154699903 | CID_154699903 | |
| 0.357 | 0.032 | 0.357 | Transcription factor STAT inhibitor | |||
| 0.346 | 0.022 | 0.346 | P-glycoprotein inhibitor | 0.267 0.036 CID_154699903 | ||
| 0.338 | 0.015 | 0.507 | Interferon gamma antagonist | 0.507 0.006 CID_154699903 | CID_154699903 | |
| 0.402 | 0.08 | 0.402 | Calcium channel L-type activator | |||
| 0.326 | 0.005 | 0.33 | Carbonic anhydrase XIII inhibitor | 0.33 0.005 CID_154699903 | CID_154699903 | |
| 0.331 | 0.011 | 0.331 | Cyclooxygenase 1 inhibitor | 0.192 0.038 CID_154699903 | ||
| 0.332 | 0.012 | 0.332 | MAO A inhibitor | |||
| 0.325 | 0.007 | 0.325 | Nitric-oxide synthase stimulant | 0.324 0.007 CID_154699903 | ||
| 0.326 | 0.011 | 0.326 | MAO B inhibitor | |||
| 0.353 | 0.04 | 0.384 | DNA damaging | 0.384 0.032 CID_154699903 | CID_154699903 | |
| 0.32 | 0.014 | 0.32 | Tumour necrosis factor antagonist | |||
| 0.324 | 0.019 | 0.438 | DNA methyltransferase I inhibitor | 0.438 0.006 CID_154699903 | CID_154699903 | |
| 0.306 | 0.005 | 0.306 | Estrogen receptor beta antagonist | |||
| 0.304 | 0.006 | 0.711 | Beta glucuronidase inhibitor | 0.711 0.002 CID_154699903 | CID_154699903 | |
| 0.302 | 0.01 | 0.302 | Succinate dehydrogenase inhibitor | 0.168 0.083 CID_154699903 | ||
| 0.358 | 0.068 | 0.446 | Angiogenesis inhibitor | 0.446 0.041 CID_154699903 | CID_154699903 | |
| 0.33 | 0.043 | 0.537 | Tumour necrosis factor alpha release inhibitor | 0.537 0.011 CID_154699903 | CID_154699903 | |
| 0.291 | 0.005 | 0.291 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.293 | 0.008 | 0.45 | Xanthine oxidase inhibitor | 0.45 0.004 CID_154699903 | CID_154699903 | |
| 0.323 | 0.038 | 0.482 | Interleukin agonist | 0.482 0.01 CID_154699903 | CID_154699903 | |
| 0.291 | 0.007 | 0.291 | Histidine decarboxylase inhibitor | |||
| 0.295 | 0.011 | 0.295 | Chelator | 0.107 0.067 CID_154699903 | ||
| 0.307 | 0.026 | 0.445 | DNA methylase inhibitor | 0.445 0.008 CID_154699903 | CID_154699903 | |
| 0.279 | 0.006 | 0.279 | Toll-Like receptor 2 antagonist | 0.147 0.055 CID_154699903 | ||
| 0.287 | 0.013 | 0.287 | Cholesterol synthesis inhibitor | 0.21 0.024 CID_154699903 | ||
| 0.285 | 0.023 | 0.289 | Neurotrophic factor enhancer | 0.289 0.021 CID_154699903 | CID_154699903 | |
| 0.4 | 0.139 | 0.8 | Antiinflammatory | 0.8 0.015 CID_154699903 | CID_154699903 | |
| 0.279 | 0.018 | 0.279 | Heat shock protein 90 alpha antagonist | |||
| 0.322 | 0.062 | 0.431 | Spasmolytic | 0.431 0.034 CID_154699903 | CID_154699903 | |
| 0.304 | 0.048 | 0.804 | Angiogenesis stimulant | 0.804 0.004 CID_154699903 | CID_154699903 | |
| 0.321 | 0.071 | 0.321 | Streptokinase A inhibitor | |||
| 0.351 | 0.101 | 0.668 | Antibacterial | 0.668 0.011 CID_154699903 | CID_154699903 | |
| 0.252 | 0.005 | 0.252 | Histone deacetylase SIRT1 stimulant | 0.218 0.005 CID_154699903 | ||
| 0.252 | 0.005 | 0.252 | Histone deacetylase stimulant | 0.218 0.005 CID_154699903 | ||
| 0.252 | 0.006 | 0.252 | HIV-1 integrase (3'-Processing) inhibitor | 0.116 0.02 CID_154699903 | ||
| 0.282 | 0.038 | 0.282 | Anesthetic general | 0.263 0.045 CID_154699903 | ||
| 0.302 | 0.057 | 0.302 | Insulysin inhibitor | |||
| 0.25 | 0.006 | 0.25 | Estrogen agonist | 0.092 0.019 CID_154699903 | ||
| 0.311 | 0.069 | 0.311 | Sodium/bile acid cotransporter inhibitor | 0.229 0.152 CID_154699903 | ||
| 0.331 | 0.089 | 0.331 | Prostaglandin dehydrogenase inhibitor | |||
| 0.259 | 0.018 | 0.265 | Alkaline phosphatase inhibitor | 0.265 0.017 CID_154699903 | CID_154699903 | |
| 0.274 | 0.034 | 0.545 | Non-steroidal antiinflammatory agent | 0.545 0.005 CID_154699903 | CID_154699903 | |
| 0.257 | 0.019 | 0.257 | Heat shock protein 90 antagonist | |||
| 0.264 | 0.027 | 0.264 | Insulin sensitizer | 0.258 0.03 CID_154699903 | ||
| 0.247 | 0.012 | 0.247 | Interleukin 1b antagonist | 0.169 0.029 CID_154699903 | ||
| 0.312 | 0.081 | 0.735 | Antithrombotic | 0.735 0.006 CID_154699903 | CID_154699903 | |
| 0.238 | 0.008 | 0.238 | CF transmembrane conductance regulator agonist | 0.177 0.039 CID_154699903 | ||
| 0.235 | 0.006 | 0.235 | TRPA1 agonist | 0.152 0.03 CID_154699903 | ||
| 0.266 | 0.039 | 0.55 | Hepatoprotectant | 0.55 0.005 CID_154699903 | CID_154699903 | |
| 0.235 | 0.01 | 0.61 | Cyclooxygenase 3 inhibitor | 0.61 0.002 CID_154699903 | CID_154699903 | |
| 0.244 | 0.019 | 0.244 | Aldehyde dehydrogenase inhibitor | 0.204 0.027 CID_154699903 | ||
| 0.274 | 0.05 | 0.274 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.246 | 0.027 | 0.246 | Cyclooxygenase inhibitor | 0.159 0.063 CID_154699903 | ||
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.232 | 0.021 | 0.406 | Hexokinase inhibitor | 0.406 0.004 CID_154699903 | CID_154699903 | |
| 0.234 | 0.024 | 0.234 | NADPH oxidase inhibitor | 0.163 0.047 CID_154699903 | ||
| 0.218 | 0.008 | 0.218 | Vanilloid 1 agonist | 0.195 0.013 CID_154699903 | ||
| 0.217 | 0.008 | 0.217 | HIV-1 integrase (Strand Transfer) inhibitor | 0.101 0.022 CID_154699903 | ||
| 0.236 | 0.028 | 0.236 | Phospholipase C inhibitor | 0.194 0.048 CID_154699903 | ||
| 0.254 | 0.047 | 0.254 | RNA-directed DNA polymerase inhibitor | 0.213 0.082 CID_154699903 | ||
| 0.21 | 0.005 | 0.21 | DOPA decarboxylase inhibitor | |||
| 0.246 | 0.041 | 0.246 | Dual specificity phosphatase 3 inhibitor | |||
| 0.229 | 0.025 | 0.229 | Neurotensin receptor agonist | |||
| 0.226 | 0.024 | 0.226 | Interleukin 1 antagonist | 0.12 0.088 CID_154699903 | ||
| 0.208 | 0.008 | 0.208 | Thioredoxin inhibitor | 0.204 0.008 CID_154699903 | ||
| 0.234 | 0.034 | 0.234 | Histone acetyltransferase inhibitor | |||
| 0.218 | 0.018 | 0.218 | Interleukin 4 antagonist | 0.175 0.032 CID_154699903 | ||
| 0.207 | 0.008 | 0.207 | Estrogen receptor alpha antagonist | |||
| 0.217 | 0.017 | 0.217 | Farnesoid X receptor antagonist | |||
| 0.258 | 0.059 | 0.258 | Interleukin antagonist | |||
| 0.232 | 0.036 | 0.232 | Protein-tyrosine phosphatase inhibitor | 0.198 0.047 CID_154699903 | ||
| 0.201 | 0.006 | 0.209 | Heat shock protein 70 antagonist | 0.209 0.005 CID_154699903 | CID_154699903 | |
| 0.233 | 0.042 | 0.233 | Dual specificity phosphatase inhibitor | |||
| 0.33 | 0.139 | 0.33 | Transcription factor inhibitor | |||
| 0.201 | 0.01 | 0.201 | Creatine kinase inhibitor | |||
| 0.241 | 0.052 | 0.474 | Platelet adhesion inhibitor | 0.474 0.006 CID_154699903 | CID_154699903 | |
| 0.206 | 0.018 | 0.247 | Microtubule formation inhibitor | 0.247 0.01 CID_154699903 | CID_154699903 | |
| 0.334 | 0.147 | 0.334 | DNA polymerase beta inhibitor | |||
| 0.214 | 0.027 | 0.355 | ATPase inhibitor | 0.355 0.004 CID_154699903 | CID_154699903 | |
| 0.205 | 0.019 | 0.535 | Expectorant | 0.535 0.003 CID_154699903 | CID_154699903 | |
| 0.252 | 0.068 | 0.402 | Vasodilator | 0.402 0.023 CID_154699903 | CID_154699903 | |
| 0.207 | 0.026 | 0.207 | DNA polymerase I inhibitor | 0.204 0.027 CID_154699903 | ||
| 0.211 | 0.031 | 0.395 | Alpha-N-acetylglucosaminidase inhibitor | 0.395 0.009 CID_154699903 | CID_154699903 | |
| 0.195 | 0.015 | 0.25 | Topoisomerase II alpha inhibitor | 0.25 0.01 CID_154699903 | CID_154699903 | |
| 0.237 | 0.058 | 0.237 | ErbB-1 antagonist | |||
| 0.218 | 0.039 | 0.218 | Cytidine deaminase inhibitor | |||
| 0.21 | 0.031 | 0.321 | Topoisomerase II inhibitor | 0.321 0.016 CID_154699903 | CID_154699903 | |
| 0.194 | 0.016 | 0.194 | Adenylate cyclase stimulant | 0.137 0.086 CID_154699903 | ||
| 0.203 | 0.029 | 0.216 | Mannose-6-phosphate isomerase inhibitor | 0.216 0.023 CID_154699903 | CID_154699903 | |
| 0.189 | 0.016 | 0.198 | Mucolytic | 0.198 0.014 CID_154699903 | CID_154699903 | |
| 0.181 | 0.009 | 0.181 | Carbonic anhydrase V inhibitor | |||
| 0.239 | 0.068 | 0.239 | Neuropeptide Y2 antagonist | |||
| 0.2 | 0.029 | 0.2 | Protein-tyrosine phosphatase 1B inhibitor | 0.198 0.03 CID_154699903 | ||
| 0.223 | 0.053 | 0.223 | I kappa B kinase epsilon inhibitor | |||
| 0.263 | 0.095 | 0.263 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.173 | 0.005 | 0.173 | Estrogen receptor beta agonist | 0.035 0.022 CID_154699903 | ||
| 0.2 | 0.033 | 0.2 | Arachidonic acid antagonist | 0.126 0.118 CID_154699903 | ||
| 0.173 | 0.008 | 0.173 | Myeloperoxidase inhibitor | |||
| 0.181 | 0.016 | 0.181 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.198 | 0.034 | 0.198 | Acetylcholinesterase inhibitor | |||
| 0.197 | 0.034 | 0.197 | Catenin beta inhibitor | |||
| 0.174 | 0.011 | 0.201 | Toll-Like receptor 4 antagonist | 0.201 0.006 CID_154699903 | CID_154699903 | |
| 0.176 | 0.014 | 0.176 | Prolactin inhibitor | |||
| 0.178 | 0.018 | 0.261 | Photosensitizer | 0.261 0.005 CID_154699903 | CID_154699903 | |
| 0.314 | 0.155 | 0.314 | DNA directed DNA polymerase inhibitor | |||
| 0.233 | 0.075 | 0.233 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.164 | 0.008 | 0.164 | Carbonic anhydrase VA inhibitor | |||
| 0.234 | 0.079 | 0.389 | DNA synthesis inhibitor | 0.389 0.023 CID_154699903 | CID_154699903 | |
| 0.162 | 0.01 | 0.162 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.221 | 0.07 | 0.229 | Psychostimulant | 0.229 0.067 CID_154699903 | CID_154699903 | |
| 0.158 | 0.008 | 0.158 | Carbonic anhydrase VB inhibitor | |||
| 0.154 | 0.005 | 0.154 | Estrogen receptor alpha agonist | |||
| 0.194 | 0.046 | 0.194 | Phospholipase A2 inhibitor | 0.161 0.065 CID_154699903 | ||
| 0.15 | 0.004 | 0.15 | Estrogen-related receptor beta agonist | |||
| 0.165 | 0.019 | 0.165 | Sphingomyelinase inhibitor | 0.149 0.025 CID_154699903 | ||
| 0.155 | 0.01 | 0.155 | Alcohol oxidase inhibitor | |||
| 0.182 | 0.037 | 0.182 | Cyclooxygenase 2 inhibitor | 0.123 0.077 CID_154699903 | ||
| 0.172 | 0.028 | 0.193 | Beta amyloid protein antagonist | 0.193 0.019 CID_154699903 | CID_154699903 | |
| 0.149 | 0.007 | 0.149 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.144 0.008 CID_154699903 | ||
| 0.162 | 0.022 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.156 0.029 CID_154699903 | ||
| 0.163 | 0.023 | 0.447 | Mediator release inhibitor | 0.447 0.004 CID_154699903 | CID_154699903 | |
| 0.152 | 0.013 | 0.152 | Glutamate decarboxylase inhibitor | |||
| 0.148 | 0.01 | 0.148 | Leukotriene antagonist | 0.135 0.012 CID_154699903 | ||
| 0.226 | 0.089 | 0.226 | Calpain inhibitor | |||
| 0.161 | 0.025 | 0.161 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.163 | 0.027 | 0.163 | Bronchodilator | |||
| 0.141 | 0.007 | 0.141 | D-Ala-D-Ala ligase inhibitor | |||
| 0.139 | 0.005 | 0.139 | Aryl hydrocarbon receptor antagonist | |||
| 0.14 | 0.007 | 0.14 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.172 | 0.04 | 0.172 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.192 | 0.06 | 0.192 | Mcl-1 antagonist | |||
| 0.14 | 0.008 | 0.14 | Xanthine dehydrogenase inhibitor | 0.07 0.032 CID_154699903 | ||
| 0.218 | 0.088 | 0.218 | Dyrk kinase inhibitor | |||
| 0.138 | 0.009 | 0.138 | Purinergic P2X1 antagonist | 0.075 0.028 CID_154699903 | ||
| 0.134 | 0.009 | 0.134 | Elastase 1 inhibitor | |||
| 0.139 | 0.015 | 0.139 | Ornithine decarboxylase inhibitor | 0.116 0.028 CID_154699903 | ||
| 0.145 | 0.021 | 0.145 | Anabolic | |||
| 0.157 | 0.033 | 0.157 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.151 | 0.028 | 0.151 | Potassium channel (Ca-activated) activator | |||
| 0.13 | 0.007 | 0.13 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.139 | 0.017 | 0.146 | Interleukin 12 antagonist | 0.146 0.014 CID_154699903 | CID_154699903 | |
| 0.152 | 0.03 | 0.305 | DNA repair enzyme inhibitor | 0.305 0.004 CID_154699903 | CID_154699903 | |
| 0.147 | 0.025 | 0.147 | Urease inhibitor | |||
| 0.15 | 0.029 | 0.438 | AMP-activated protein kinase stimulant | 0.438 0.004 CID_154699903 | CID_154699903 | |
| 0.163 | 0.042 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.126 | 0.006 | 0.243 | Carbonic anhydrase XIV inhibitor | 0.243 0.004 CID_154699903 | CID_154699903 | |
| 0.144 | 0.024 | 0.144 | Electron transport complex I inhibitor | |||
| 0.125 | 0.006 | 0.125 | GABA B receptor agonist | |||
| 0.132 | 0.013 | 0.132 | Thioredoxin reductase inhibitor | 0.081 0.06 CID_154699903 | ||
| 0.129 | 0.014 | 0.129 | Bile acid receptor antagonist | 0.094 0.063 CID_154699903 | ||
| 0.156 | 0.041 | 0.156 | Antibacterial (Helicobacter pylori) | |||
| 0.119 | 0.004 | 0.141 | Glucose-6-phosphate translocase inhibitor | 0.141 0.004 CID_154699903 | CID_154699903 | |
| 0.143 | 0.029 | 0.221 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.221 0.013 CID_154699903 | CID_154699903 | |
| 0.136 | 0.022 | 0.258 | NADH dehydrogenase inhibitor | 0.258 0.008 CID_154699903 | CID_154699903 | |
| 0.138 | 0.025 | 0.147 | Acetylcholine release stimulant | 0.147 0.018 CID_154699903 | CID_154699903 | |
| 0.126 | 0.014 | 0.126 | GABA aminotransferase inhibitor | 0.117 0.017 CID_154699903 | ||
| 0.155 | 0.043 | 0.155 | Cathepsin H inhibitor | |||
| 0.129 | 0.016 | 0.129 | Aromatase inhibitor | |||
| 0.151 | 0.041 | 0.274 | Topoisomerase I inhibitor | 0.274 0.013 CID_154699903 | CID_154699903 | |
| 0.163 | 0.053 | 0.347 | Cell wall synthesis inhibitor | 0.347 0.008 CID_154699903 | CID_154699903 | |
| 0.113 | 0.004 | 0.113 | Transcription factor RelA inhibitor | |||
| 0.239 | 0.131 | 0.239 | Thyroid hormone antagonist | |||
| 0.146 | 0.038 | 0.146 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.135 | 0.029 | 0.135 | GABA C receptor rho-1 antagonist | |||
| 0.121 | 0.015 | 0.121 | HIV-1 integrase inhibitor | |||
| 0.148 | 0.042 | 0.148 | Death-associated protein kinase 1 inhibitor | |||
| 0.151 | 0.046 | 0.299 | Alkylator | 0.299 0.013 CID_154699903 | CID_154699903 | |
| 0.138 | 0.032 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 CID_154699903 | CID_154699903 | |
| 0.115 | 0.01 | 0.115 | Potassium channel (ATP-sensitive) blocker | |||
| 0.122 | 0.017 | 0.122 | Vanilloid agonist | 0.08 0.069 CID_154699903 | ||
| 0.109 | 0.005 | 0.109 | Heme oxygenase stimulant | 0.076 0.018 CID_154699903 | ||
| 0.138 | 0.034 | 0.138 | Transcription factor STAT6 inhibitor | |||
| 0.106 | 0.005 | 0.106 | Squalene epoxidase inhibitor | 0.052 0.03 CID_154699903 | ||
| 0.135 | 0.035 | 0.315 | UDP-glucose 4-epimerase inhibitor | 0.315 0.009 CID_154699903 | CID_154699903 | |
| 0.119 | 0.021 | 0.119 | Purinergic P2X2 antagonist | |||
| 0.137 | 0.039 | 0.137 | GABA C receptor agonist | |||
| 0.12 | 0.022 | 0.128 | Glutamate release inhibitor | 0.128 0.017 CID_154699903 | CID_154699903 | |
| 0.136 | 0.039 | 0.136 | GABA C receptor antagonist | |||
| 0.229 | 0.132 | 0.229 | Thyroid hormone beta antagonist | |||
| 0.111 | 0.015 | 0.111 | Glycine receptor agonist | 0.097 0.023 CID_154699903 | ||
| 0.113 | 0.019 | 0.113 | Leukotriene synthesis inhibitor | |||
| 0.109 | 0.016 | 0.129 | Aldose reductase inhibitor | 0.129 0.013 CID_154699903 | CID_154699903 | |
| 0.097 | 0.005 | 0.097 | Ryanodine receptor antagonist | |||
| 0.095 | 0.003 | 0.095 | CYP24 inhibitor | 0.025 0.013 CID_154699903 | ||
| 0.117 | 0.026 | 0.117 | Inducible nitric-oxide synthase inhibitor | |||
| 0.146 | 0.058 | 0.146 | Nav1.6 sodium channel blocker | |||
| 0.166 | 0.078 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | |||
| 0.098 | 0.011 | 0.156 | Leukotriene B4 antagonist | 0.156 0.005 CID_154699903 | CID_154699903 | |
| 0.148 | 0.061 | 0.148 | Bone formation stimulant | 0.122 0.083 CID_154699903 | ||
| 0.189 | 0.103 | 0.368 | Hypolipemic | 0.368 0.031 CID_154699903 | CID_154699903 | |
| 0.131 | 0.044 | 0.131 | Protein kinase C gamma inhibitor | |||
| 0.103 | 0.017 | 0.103 | TRPA1 antagonist | |||
| 0.115 | 0.03 | 0.166 | Phosphodiesterase 6D inhibitor | 0.166 0.007 CID_154699903 | CID_154699903 | |
| 0.193 | 0.109 | 0.409 | Peptidyltransferase inhibitor | 0.409 0.006 CID_154699903 | CID_154699903 | |
| 0.144 | 0.06 | 0.144 | Toll-Like receptor antagonist | |||
| 0.088 | 0.005 | 0.088 | Adenylate cyclase 1 inhibitor | |||
| 0.129 | 0.048 | 0.129 | Falcipain 3 inhibitor | |||
| 0.097 | 0.016 | 0.097 | 5 Hydroxytryptamine 2A agonist | |||
| 0.125 | 0.044 | 0.125 | Butyrylcholinesterase inhibitor | |||
| 0.09 | 0.011 | 0.09 | Carbonic anhydrase VII inhibitor | 0.046 0.033 CID_154699903 | ||
| 0.121 | 0.042 | 0.121 | Gastric antisecretory | |||
| 0.114 | 0.036 | 0.114 | Phosphodiesterase IV inhibitor | |||
| 0.115 | 0.038 | 0.115 | Alcohol dehydrogenase inhibitor | 0.095 0.058 CID_154699903 | ||
| 0.083 | 0.006 | 0.083 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.235 | 0.16 | 0.235 | Calpain 2 inhibitor | |||
| 0.092 | 0.017 | 0.092 | Beta 3 adrenoreceptor antagonist | |||
| 0.126 | 0.052 | 0.126 | Caspase 3 inhibitor | |||
| 0.132 | 0.058 | 0.132 | Anesthetic local | |||
| 0.093 | 0.02 | 0.093 | MAP kinase kinase 7 inhibitor | |||
| 0.106 | 0.033 | 0.106 | Porphobilinogen synthase inhibitor | |||
| 0.087 | 0.014 | 0.087 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.145 | 0.072 | 0.145 | Neuropeptide Y1 antagonist | |||
| 0.112 | 0.04 | 0.112 | Calcium antagonist | |||
| 0.108 | 0.036 | 0.108 | Catalase inhibitor | |||
| 0.08 | 0.008 | 0.08 | Estrogen-related receptor alpha antagonist | |||
| 0.105 | 0.033 | 0.139 | ATPase (Vacuolar H+) inhibitor | 0.139 0.01 CID_154699903 | CID_154699903 | |
| 0.078 | 0.007 | 0.078 | Dopamine D5 agonist | |||
| 0.104 | 0.034 | 0.104 | Glutathione S-transferase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Leukotriene C antagonist | |||
| 0.109 | 0.041 | 0.109 | Protein kinase C zeta inhibitor | |||
| 0.11 | 0.042 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | |||
| 0.089 | 0.022 | 0.089 | Beta adrenoreceptor antagonist | |||
| 0.231 | 0.165 | 0.521 | Immunosuppressant | 0.521 0.027 CID_154699903 | CID_154699903 | |
| 0.178 | 0.112 | 0.178 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.071 | 0.005 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.109 | 0.044 | 0.109 | Glutamate (mGluR7) agonist | |||
| 0.078 | 0.013 | 0.078 | Potassium channel Kv1.3 blocker | |||
| 0.079 | 0.015 | 0.079 | Calcium channel P-type blocker | |||
| 0.068 | 0.005 | 0.068 | NMDA 2D receptor antagonist | 0.025 0.023 CID_154699903 | ||
| 0.08 | 0.018 | 0.08 | Cyclin D1 inhibitor | |||
| 0.135 | 0.074 | 0.135 | Neurotrophic factor | 0.124 0.089 CID_154699903 | ||
| 0.084 | 0.023 | 0.084 | Maillard reaction inhibitor | |||
| 0.081 | 0.02 | 0.081 | Heat shock protein 90 beta antagonist | |||
| 0.077 | 0.017 | 0.077 | Sphingosine kinase 2 inhibitor | |||
| 0.092 | 0.033 | 0.092 | CDC25A inhibitor | |||
| 0.187 | 0.128 | 0.481 | Immunostimulant | 0.481 0.031 CID_154699903 | CID_154699903 | |
| 0.123 | 0.065 | 0.123 | Adenylate cyclase inhibitor | |||
| 0.072 | 0.015 | 0.072 | Dihydroorotate oxidase inhibitor | |||
| 0.102 | 0.046 | 0.218 | Triose-phosphate isomerase inhibitor | 0.218 0.009 CID_154699903 | CID_154699903 | |
| 0.061 | 0.005 | 0.061 | Vanilloid 3 antagonist | |||
| 0.071 | 0.015 | 0.071 | Glutamate (mGluR group III) agonist | |||
| 0.063 | 0.007 | 0.063 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.093 | 0.038 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 CID_154699903 | CID_154699903 | |
| 0.077 | 0.021 | 0.077 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.1 | 0.046 | 0.1 | Androgen antagonist | |||
| 0.066 | 0.013 | 0.07 | Factor III inhibitor | 0.07 0.011 CID_154699903 | CID_154699903 | |
| 0.079 | 0.026 | 0.079 | Exportin-1 inhibitor | |||
| 0.084 | 0.031 | 0.084 | Dopamine D1 antagonist | |||
| 0.064 | 0.011 | 0.064 | Dopamine beta hydroxylase inhibitor | |||
| 0.101 | 0.049 | 0.101 | ABCA1 expression enhancer | |||
| 0.074 | 0.022 | 0.074 | Beta 1 adrenoreceptor antagonist | |||
| 0.089 | 0.038 | 0.089 | NMDA 2 receptor antagonist | |||
| 0.06 | 0.009 | 0.06 | Leukotriene D4 antagonist | |||
| 0.135 | 0.085 | 0.135 | Pregnane X receptor agonist | |||
| 0.054 | 0.005 | 0.054 | Estrogen-related receptor beta antagonist | |||
| 0.113 | 0.064 | 0.113 | Nav1.5 sodium channel blocker | |||
| 0.065 | 0.016 | 0.273 | Heparanase inhibitor | 0.273 0.002 CID_154699903 | CID_154699903 | |
| 0.081 | 0.033 | 0.081 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.093 | 0.046 | 0.093 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.126 | 0.08 | 0.126 | Toll-Like receptor 9 antagonist | |||
| 0.111 | 0.065 | 0.111 | Polo-like kinase-4 inhibitor | |||
| 0.074 | 0.029 | 0.074 | Protease activated receptor antagonist | |||
| 0.114 | 0.07 | 0.114 | Proteasome inhibitor | |||
| 0.057 | 0.014 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 CID_154699903 | CID_154699903 | |
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.063 | 0.02 | 0.063 | Vanilloid 2 antagonist | |||
| 0.052 | 0.009 | 0.052 | Leukotriene C4 antagonist | |||
| 0.126 | 0.084 | 0.126 | Cytokine production inhibitor | |||
| 0.063 | 0.021 | 0.063 | Beta 2 adrenoreceptor antagonist | |||
| 0.065 | 0.024 | 0.065 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.067 | 0.026 | 0.067 | Beta 2 adrenoreceptor agonist | |||
| 0.055 | 0.014 | 0.055 | Dihydropteroate synthase inhibitor | |||
| 0.056 | 0.015 | 0.056 | Liver X receptor alpha agonist | |||
| 0.079 | 0.038 | 0.079 | Amidase inhibitor | |||
| 0.053 | 0.015 | 0.053 | Dihydrofolate reductase inhibitor | |||
| 0.063 | 0.024 | 0.063 | Lysine-specific demethylase 1A inhibitor | |||
| 0.08 | 0.041 | 0.087 | Phosphodiesterase VI inhibitor | 0.087 0.031 CID_154699903 | CID_154699903 | |
| 0.079 | 0.041 | 0.079 | Peroxisome proliferator-activated receptor gamma agonist | 0.063 0.055 CID_154699903 | ||
| 0.042 | 0.005 | 0.042 | Estrogen-related receptor gamma antagonist | |||
| 0.044 | 0.008 | 0.044 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.068 | 0.032 | 0.075 | Transcription factor AP-1 inhibitor | 0.075 0.026 CID_154699903 | CID_154699903 | |
| 0.043 | 0.008 | 0.129 | Sodium/glucose cotransporter 2 inhibitor | 0.129 0.002 CID_154699903 | CID_154699903 | |
| 0.045 | 0.01 | 0.045 | Catechol O-methyltransferase inhibitor | |||
| 0.071 | 0.037 | 0.071 | CDC25B inhibitor | |||
| 0.077 | 0.043 | 0.168 | Phosphofructokinase-1 inhibitor | 0.168 0.015 CID_154699903 | CID_154699903 | |
| 0.1 | 0.067 | 0.1 | Adenylate kinase inhibitor | |||
| 0.074 | 0.041 | 0.074 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.203 | 0.17 | 0.203 | Thioredoxin glutathione reductase inhibitor | |||
| 0.043 | 0.011 | 0.043 | ATP citrate lysase inhibitor | |||
| 0.129 | 0.097 | 0.129 | Cholinergic | |||
| 0.097 | 0.066 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.056 | 0.025 | 0.056 | Topoisomerase II beta inhibitor | |||
| 0.064 | 0.033 | 0.064 | Sphingosine kinase inhibitor | |||
| 0.072 | 0.042 | 0.072 | Potassium channel large-conductance Ca-activated activator | |||
| 0.143 | 0.113 | 0.143 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.076 | 0.047 | 0.076 | Metalloproteinase-9 inhibitor | |||
| 0.08 | 0.05 | 0.08 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.041 | 0.011 | 0.056 | Uridine phosphorylase inhibitor | 0.056 0.006 CID_154699903 | CID_154699903 | |
| 0.042 | 0.013 | 0.042 | Tubulin agonist | 0.034 0.024 CID_154699903 | ||
| 0.046 | 0.017 | 0.046 | Farnesoid X receptor agonist | |||
| 0.063 | 0.034 | 0.063 | Fibroblast growth factor 4 antagonist | |||
| 0.092 | 0.064 | 0.092 | Fibroblast growth factor 1 antagonist | |||
| 0.067 | 0.04 | 0.126 | Neuraminidase (influenza) inhibitor | 0.126 0.01 CID_154699903 | CID_154699903 | |
| 0.067 | 0.04 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.053 | 0.026 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_154699903 | CID_154699903 | |
| 0.127 | 0.101 | 0.324 | Insulin secretagoues | 0.324 0.01 CID_154699903 | CID_154699903 | |
| 0.274 | 0.249 | 0.274 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.081 | 0.056 | 0.081 | Adrenaline agonist | |||
| 0.034 | 0.009 | 0.129 | Sodium/glucose cotransporter inhibitor | 0.129 0.002 CID_154699903 | CID_154699903 | |
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | |||
| 0.086 | 0.061 | 0.088 | Interleukin 5 antagonist | 0.088 0.058 CID_154699903 | CID_154699903 | |
| 0.09 | 0.065 | 0.147 | Uric acid excretion stimulant | 0.147 0.024 CID_154699903 | CID_154699903 | |
| 0.084 | 0.06 | 0.084 | NMDA receptor antagonist | |||
| 0.058 | 0.034 | 0.058 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.039 | 0.061 | Biliverdin reductase inhibitor | |||
| 0.053 | 0.031 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.136 | 0.114 | 0.236 | Interleukin 6 antagonist | 0.236 0.026 CID_154699903 | CID_154699903 | |
| 0.118 | 0.097 | 0.118 | CDC-like kinase 1 inhibitor | |||
| 0.055 | 0.034 | 0.118 | Alpha-mannosidase inhibitor | 0.118 0.005 CID_154699903 | CID_154699903 | |
| 0.053 | 0.033 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.072 | 0.053 | 0.072 | Phosphodiesterase 4D inhibitor | |||
| 0.062 | 0.043 | 0.062 | NMDA 2C receptor antagonist | |||
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | |||
| 0.059 | 0.04 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.047 | 0.028 | 0.047 | Dihydroorotase inhibitor | |||
| 0.03 | 0.012 | 0.03 | Hedgehog signaling activator | |||
| 0.051 | 0.033 | 0.051 | CD45 antagonist | |||
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | |||
| 0.042 | 0.024 | 0.042 | Alpha 1d adrenoreceptor agonist | |||
| 0.095 | 0.077 | 0.095 | Ferrochelatase inhibitor | |||
| 0.039 | 0.022 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.023 | 0.006 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_154699903 | CID_154699903 | |
| 0.026 | 0.009 | 0.026 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.048 | 0.032 | 0.048 | Glycine transporter 2 inhibitor | |||
| 0.027 | 0.011 | 0.027 | Prostaglandin F2 alpha agonist | |||
| 0.032 | 0.017 | 0.032 | Liver X receptor alpha antagonist | |||
| 0.045 | 0.03 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.123 | 0.109 | 0.424 | Hemostatic | 0.424 0.006 CID_154699903 | CID_154699903 | |
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | 0.023 0.014 CID_154699903 | ||
| 0.04 | 0.027 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.079 | 0.067 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.089 | 0.077 | 0.089 | Alpha 2c adrenoreceptor antagonist | |||
| 0.068 | 0.056 | 0.068 | Lipase inhibitor | |||
| 0.039 | 0.028 | 0.039 | GABA uptake inhibitor | |||
| 0.055 | 0.043 | 0.055 | Fatty acid synthase inhibitor | |||
| 0.03 | 0.018 | 0.03 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_154699903 | ||
| 0.027 | 0.016 | 0.027 | Thyroid hormone agonist | |||
| 0.02 | 0.01 | 0.02 | Estrogen-related receptor gamma agonist | |||
| 0.024 | 0.013 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.026 0.011 CID_154699903 | CID_154699903 | |
| 0.08 | 0.069 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.035 | 0.024 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Liver X receptor beta antagonist | |||
| 0.031 | 0.022 | 0.031 | Prostaglandin agonist | |||
| 0.069 | 0.06 | 0.069 | Adenosine A3 receptor antagonist | |||
| 0.064 | 0.055 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.055 | 0.046 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 CID_154699903 | CID_154699903 | |
| 0.183 | 0.175 | 0.183 | Gastrin inhibitor | |||
| 0.046 | 0.038 | 0.046 | Plasminogen activator inhibitor antagonist | |||
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.071 | 0.064 | 0.241 | Antineoplastic antibiotic | 0.241 0.015 CID_154699903 | CID_154699903 | |
| 0.044 | 0.037 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.069 | 0.062 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.053 | 0.047 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 CID_154699903 | CID_154699903 | |
| 0.022 | 0.017 | 0.022 | Retinoic acid gamma receptor agonist | |||
| 0.1 | 0.095 | 0.1 | Interleukin 8 antagonist | |||
| 0.07 | 0.065 | 0.07 | Metalloproteinase-2 inhibitor | |||
| 0.08 | 0.076 | 0.08 | Protein kinase C delta inhibitor | |||
| 0.054 | 0.05 | 0.054 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.029 | 0.025 | 0.029 | HCV NS5B polymerase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.075 | 0.071 | 0.075 | Bcr-Abl kinase inhibitor | |||
| 0.051 | 0.047 | 0.051 | Epithelial sodium channel blocker | |||
| 0.041 | 0.038 | 0.12 | Mannosidase inhibitor | 0.12 0.005 CID_154699903 | CID_154699903 | |
| 0.024 | 0.021 | 0.038 | Vanilloid 2 agonist | 0.038 0.004 CID_154699903 | CID_154699903 | |
| 0.022 | 0.019 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.03 | 0.028 | 0.03 | Liver X receptor beta agonist | |||
| 0.046 | 0.043 | 0.046 | H+/K+-transporting ATPase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Melatonin 2 agonist | |||
| 0.035 | 0.033 | 0.035 | Retinoid X receptor antagonist | |||
| 0.038 | 0.037 | 0.038 | Plasmepsin II inhibitor | |||
| 0.041 | 0.04 | 0.041 | Heme oxygenase inhibitor | |||
| 0.053 | 0.052 | 0.104 | Neuraminidase inhibitor | 0.104 0.014 CID_154699903 | CID_154699903 | |
| 0.053 | 0.052 | 0.053 | Androgen agonist | |||
| 0.09 | 0.089 | 0.09 | 5 Hydroxytryptamine 3A agonist | |||
| 0.048 | 0.052 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 CID_154699903 | CID_154699903 | |
| 0.012 | 0.019 | 0.037 | Ileal bile acid transport inhibitor | 0.037 0.004 CID_154699903 | CID_154699903 | |
| 0.007 | 0.017 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699903 | CID_154699903 | |
| 0.013 | 0.024 | 0.018 | Telomerase stimulant | 0.018 0.01 CID_154699903 | CID_154699903 | |
| 0.223 | 0.244 | 0.796 | Cyclophilin D inhibitor | 0.796 0.007 CID_154699903 | CID_154699903 | |
| 0.079 | 0.104 | 0.163 | DNA intercalator | 0.163 0.037 CID_154699903 | CID_154699903 | |
| 0.015 | 0.04 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699903 | CID_154699903 | |
| 0.07 | 0.1 | 0.162 | Transcription factor NF kappa B stimulant | 0.162 0.014 CID_154699903 | CID_154699903 | |
| 0.026 | 0.062 | 0.062 | Carbonic anhydrase XII inhibitor | 0.062 0.032 CID_154699903 | CID_154699903 | |
| 0.012 | 0.052 | 0.053 | Squalene synthetase inhibitor | 0.053 0.013 CID_154699903 | CID_154699903 | |
| 0.044 | 0.084 | 0.082 | Nitric oxide donor | 0.082 0.02 CID_154699903 | CID_154699903 | |
| 0.019 | 0.061 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_154699903 | CID_154699903 | |
| 0.025 | 0.069 | 0.096 | Phosphorylase inhibitor | 0.096 0.014 CID_154699903 | CID_154699903 | |
| 0.012 | 0.066 | 0.045 | Arginase inhibitor | 0.045 0.019 CID_154699903 | CID_154699903 | |
| 0.056 | 0.112 | 0.101 | Glycine receptor antagonist | 0.101 0.032 CID_154699903 | CID_154699903 | |
| 0.027 | 0.098 | 0.051 | Microtubule stabilization | 0.051 0.026 CID_154699903 | CID_154699903 | |
| 0.171 | 0.246 | 0.425 | Interleukin 2 agonist | 0.425 0.021 CID_154699903 | CID_154699903 | |
| 0.051 | 0.126 | 0.072 | Interferon agonist | 0.072 0.067 CID_154699903 | CID_154699903 | |
| 0.055 | 0.13 | 0.108 | Falcipain 2 inhibitor | 0.108 0.048 CID_154699903 | CID_154699903 | |
| 0.029 | 0.108 | 0.387 | Selectin antagonist | 0.387 0.003 CID_154699903 | CID_154699903 | |
| 0.056 | 0.135 | 0.109 | Falcipain inhibitor | 0.109 0.049 CID_154699903 | CID_154699903 | |
| 0.002 | 0.085 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699903 | CID_154699903 | |
| 0.042 | 0.136 | 0.066 | Lipocortins synthesis agonist | 0.066 0.025 CID_154699903 | CID_154699903 | |
| 0.023 | 0.123 | 0.116 | Protein 50S ribosomal subunit inhibitor | 0.116 0.01 CID_154699903 | CID_154699903 | |
| 0.074 | 0.175 | 0.335 | Cell adhesion inhibitor | 0.335 0.008 CID_154699903 | CID_154699903 | |
| 0.021 | 0.123 | 0.081 | Antibiotic Aminoglycoside-like | 0.081 0.004 CID_154699903 | CID_154699903 | |
| 0.106 | 0.209 | 0.353 | Platelet antagonist | 0.353 0.037 CID_154699903 | CID_154699903 | |
| 0.016 | 0.14 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CID_154699903 | CID_154699903 | |
| 0.064 | 0.189 | 0.334 | Thrombolytic | 0.334 0.019 CID_154699903 | CID_154699903 | |
| 0.062 | 0.191 | 0.097 | T cell inhibitor | 0.097 0.027 CID_154699903 | CID_154699903 | |
| 0.01 | 0.146 | 0.057 | Protein 30S ribosomal subunit inhibitor | 0.057 0.007 CID_154699903 | CID_154699903 | |
| 0.019 | 0.157 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.018 CID_154699903 | CID_154699903 | |
| 0.046 | 0.186 | 0.181 | Cell adhesion molecule inhibitor | 0.181 0.011 CID_154699903 | CID_154699903 | |
| 0.065 | 0.252 | 0.154 | Diuretic | 0.154 0.074 CID_154699903 | CID_154699903 | |
| 0.098 | 0.304 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.031 CID_154699903 | CID_154699903 | |
| 0.021 | 0.296 | 0.094 | Factor IXa inhibitor | 0.094 0.011 CID_154699903 | CID_154699903 | |
| 0.015 | 0.332 | 0.056 | DNA gyrase inhibitor | 0.056 0.055 CID_154699903 | CID_154699903 | |
| 0.015 | 0.606 | 0.221 | Anticoagulant | 0.221 0.046 CID_154699903 | CID_154699903 | |
| 0.031 | 0.704 | 0.386 | Immunomodulator | 0.386 0.048 CID_154699903 | CID_154699903 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |